Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Phase II Study to Assess the Efficacy of 28 Day Oral Administration of AZD1236 in Adult Patients With Cystic Fibrosis

NCT00812045 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00812045
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00812045 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Double-Blind, Placebo-Controlled, Parallel Group, Phase II Study to Assess the Efficacy of 28 Day Oral Administration of AZD1236 in Adult Patients With Cystic Fibrosis
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Withdrawn
Start date
December 31, 2009
Completion date
August 31, 2010
Enrollment
44 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis